126 related articles for article (PubMed ID: 38521429)
21. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
[TBL] [Abstract][Full Text] [Related]
22. Urolithin A attenuates RANKL-induced osteoclastogenesis by co-regulating the p38 MAPK and Nrf2 signaling pathway.
Wei W; Peng C; Gu R; Yan X; Ye J; Xu Z; Sheng X; Huang G; Guo Y
Eur J Pharmacol; 2022 Apr; 921():174865. PubMed ID: 35231470
[TBL] [Abstract][Full Text] [Related]
23. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
[TBL] [Abstract][Full Text] [Related]
24. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
25. Isobavachalcone inhibits RANKL-induced osteoclastogenesis via miR-193-3p/NF-κB/NFATc1 signaling pathway in BMMs cells.
Liu X; Xu X; Li J; Shi L; Zeng Y; Tang S; Liu W; Jia L; Li Y; Zhang J
Biosci Biotechnol Biochem; 2023 Aug; 87(9):960-971. PubMed ID: 37291698
[TBL] [Abstract][Full Text] [Related]
26. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
27. Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.
Song L; Tan J; Wang Z; Ding P; Tang Q; Xia M; Wei Y; Chen L
Mol Med Rep; 2019 Jun; 19(6):4743-4752. PubMed ID: 31059030
[TBL] [Abstract][Full Text] [Related]
28. 2E-Decene-4,6-diyn-1-ol-acetate inhibits osteoclastogenesis through mitogen-activated protein kinase-c-Fos-NFATc1 signalling pathways.
Park YR; Su XD; Shrestha SK; Yang SY; Soh Y
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):341-349. PubMed ID: 34729812
[TBL] [Abstract][Full Text] [Related]
29. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
30. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z
Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
[TBL] [Abstract][Full Text] [Related]
31. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
[TBL] [Abstract][Full Text] [Related]
32. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
33. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
[TBL] [Abstract][Full Text] [Related]
34. D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways.
Chang X; Deng J; Zhou F; Geng Z; Li X; Wang S
Arch Oral Biol; 2024 May; 161():105912. PubMed ID: 38382164
[TBL] [Abstract][Full Text] [Related]
35. Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages.
Choe JY; Kim SK
Int J Mol Med; 2017 Mar; 39(3):539-548. PubMed ID: 28204822
[TBL] [Abstract][Full Text] [Related]
36. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
37. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
[TBL] [Abstract][Full Text] [Related]
38. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.
Ha H; Shim KS; An H; Kim T; Ma JY
BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684
[TBL] [Abstract][Full Text] [Related]
39. A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages.
Yu L; Jia D; Feng K; Sun X; Xu W; Ding L; Xin H; Qin L; Han T
J Ethnopharmacol; 2020 Jul; 257():112873. PubMed ID: 32298753
[TBL] [Abstract][Full Text] [Related]
40. Honokiol inhibits osteoclast differentiation and function in vitro.
Hasegawa S; Yonezawa T; Ahn JY; Cha BY; Teruya T; Takami M; Yagasaki K; Nagai K; Woo JT
Biol Pharm Bull; 2010; 33(3):487-92. PubMed ID: 20190414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]